Further to DrugAlert volume 808, HPS Pharmacies wish to advise that multiple suppliers are experiencing a supply interruption for amoxicillin products, as follows.

Product ARTG Current Status
Alphamox 500mg capsules 17679 Early December 2022
Amiloxyn 500mg capsules 185798 Late November 2022
Amoxycillin Generichealth 500mg capsules 207005 Late February 2023
Amoxycillin Sandoz 500mg capsules 63333 Late November 2022
APO-Amoxycillin 500mg capsules 208144 Early December 2022
Maxamox 1000mg tablets 76050 Early December 2022
APO-Amoxycillin 125mg/5ml Suspension 137882 Early January 2023
Amoxil 125mg/5ml Syrup 11133 Mid-November 2022
APO-Amoxycillin 250mg/5ml Suspension 137883 Early February 2023
Amoxycillin Sandoz 250mg/5ml Suspension 93720 Mid-December 2022
Amoxil Forte 250mg/5ml Syrup 11134 Mid-November 2022
Maxamox 500mg/5ml Suspension 93722 Late December 2022

Internationally registered brands of amoxicillin 250mg/5mL suspension and 500mg capsules have been approved for supply under Section 19A of the Therapeutic Goods Act 1989.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.

Download PDF

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates